http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2441348-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e673458c8c443e6fcd34bbc9565bf7f7 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-147 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-052 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D513-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4741 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4743 |
| filingDate | 2010-12-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d46b8381e63fa86153fba756561e6a48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_699b54625af7bff7f9672b9e5efd1348 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e077ec9afaaa32cdd4f789d3d1ffb3a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_50a5b8951943271dd1b4ab2978bee635 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb42fdc42c0af82c957a2ee45b64fae0 |
| publicationDate | 2014-02-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2441348-T3 |
| titleOfInvention | Tricyclic antibiotics |
| abstract | Compound of formula (I): ** Formula ** in which A1 represents -O-, -S- or -N- R3; A2 represents -CH2-, -O-, -N- R4, -C (> = O) - or -CH (O-R4) -; A3 represents C3-C8 cycloalkylene; 4 to 8 saturated and unsaturated heterocyclodiyl with 1, 2 or 3 heteroatoms selected from nitrogen, oxygen and sulfur, whose group A3 is unsubstituted or substituted; A4 represents C1-C4 alkylene, C2-C4alkenylene,> C> = O or a group selected from - C2H4NH-, - C2H4O-, and - C2H4S- linked to the adjacent group NR5- through the carbon atom; and G represents substituted or unsubstituted aryl or heteroaryl; and R1 and R2 independently of each other represent hydrogen or a substituent selected from hydroxide, halogen, mercapto, cyano, nitro, C1-C6alkyl, C1-C6alkoxy, C1-C6alkylthio, C1-C6alkylcarbonyloxy, C1-C6alkylsulfonyloxy, C1-C6heteroalkylcarbonyloxy, C5 - C6 heterocyclylcarbonyloxy, C1-C6heteroalkoxy, in which the heteroalkyl, heteroalkoxy or heterocyclyl groups comprise 1, 2 or 3 heteroatoms selected from nitrogen, oxygen and sulfur, in which substituents the alkyl moieties are unsubstituted or further substituted; R3, R4 and R5 independently one of the other represent hydrogen or C1-C6 alkyl; X1 and X2 independently of each other represent a nitrogen atom or CR2 with the proviso that, as a rule, one of X1 and X2 represents a nitrogen atom; m is 1; and fraction (CH2) m is optionally substituted by C1-C4 alkyl; halogen, carboxy, hydroxy, C1-C4 alkoxy; C1-C4-alkylcarbonyloxy, amino, mono- or di- (C1-C4 alkyl) amino or acylamino n is 0, 1 or 2 or a pharmaceutically acceptable salt thereof. |
| priorityDate | 2009-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 504.